MetLife Investment Management’s Transphorm, Inc. Common Stock TGAN Stock Holding History

MetLife Investment Management’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-17,053	Closed	-$83.7K	–	2940
2024 Q1	$83.7K	Buy	+17,053	New	+$80.9K	﹤0.01%	2616

MetLife Investment Management's TGAN Position: Q2 2024 in Review

MetLife Investment Management sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 17,053 shares — an estimated $83.7K sold.

MetLife Investment Management first reported a position in TGAN in Q1 2024 and held it in 1 quarter. The position peaked at $83.7K in Q1 2024. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

MetLife Investment Management reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
MetLife Investment Management sold 17,053 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $83.7K.
MetLife Investment Management first reported a position in Transphorm, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
MetLife Investment Management's Transphorm, Inc. Common Stock position peaked at $83.7K in Q1 2024.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on MetLife Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.